Projects per year
Personal profile
Education
- 2000 Ph. D., Department of Chemical and Materials Engineering, National Central University, Taiwan
Experience
- 2013- Professor, Center for General Education, Hsuan Chuang University
- 2013- President, Hsuan Chuang University
- 2009-2012 Dean, office of Research & Development, Taipei Medical University
- 2009-2012 Dean, office of Research & Development, Taipei Medical University
- 2008-2009 Dean, office of Student Affairs, Taipei Medical University
- 2007- Professor, Graduate Institute of Biomedical Materials Engineering, Taipei Medical University
- 2004-2006 Chief, Academia-Industry Collaboration Center, Taipei Medical University
- 2004-2007 Associate Professor, Graduate Institute of Biomedical Materials Engineering, Taipei Medical University
- 2001-2004 Assistant Professor, Graduate Institute of Biomedical Materials Engineering, Taipei Medical University
Research Interests
- Hemorheology
- Biomaterials
- Nanoparticle technology
- Liposomal vaccine
Fingerprint
- 1 Similar Profiles
Network
-
Development of Immuno-Enhancing Drug-Loaded Mpeg-Nanocarrier to Kill Colon Tumor and to Enhance Anticancer Efficacy of T Cells in Tumor Microenvironment( III )
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
Development of Minoxidil Encapsulated Liposome Fused with Adsc-Derived Exosome for Promoting Hair Regeneration(1/3)
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
CCR5標靶微脂粒包覆免疫抑制藥物Tacrolimus治療自體免疫疾病之研究(3/3)
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
發展三功能抗體(EGFR/CD3/mPEG)修飾之聚乙二醇-免疫增敏奈米藥物以主動標靶毒殺大腸癌並同時強化體內 T 細胞於腫瘤微環境抗癌功效之創新協同療法-發展新型聚乙二醇-免疫增敏奈米藥物載體以毒殺大腸癌並強化腫瘤區域T細胞之抗癌功效(2/3)
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
發展三功能抗體(EGFR/CD3/mPEG)修飾之聚乙二醇-免疫增敏奈米藥物以主動標靶毒殺大腸癌並同時強化體內 T 細胞於腫瘤微環境抗癌功效之創新協同療法-發展新型聚乙二醇-免疫增敏奈米藥物載體以毒殺大腸癌並強化腫瘤區域T細胞之抗癌功效(1/3)
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
Research output
- 101 Article
-
Antioxidative NAC-Loaded Silk Nanoparticles with Opening Mucosal Tight Junctions for Nasal Drug Delivery: An In Vitro and In Vivo Study
Chung, T. W., Wu, T. Y., Siah, Z. Y. & Liu, D. Z., Jun 2022, In: Pharmaceutics. 14, 6, 1288.Research output: Contribution to journal › Article › peer-review
Open Access -
Development of Irinotecan Liposome Armed with Dual-Target Anti-Epidermal Growth Factor Receptor and Anti-Fibroblast Activation Protein-Specific Antibody for Pancreatic Cancer Treatment
Lin, H. J., Liang, T. L., Chang, Y. Y., Liu, D. Z., Fan, J. Y., Roffler, S. R. & Lin, S. Y., Jun 2022, In: Pharmaceutics. 14, 6, 1202.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Activation of kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2/antioxidant response element pathway by curcumin enhances the anti-oxidative capacity of corneal endothelial cells
Guo, S. P., Chang, H. C., Lu, L. S., Liu, D. Z. & Wang, T. J., Sept 2021, In: Biomedicine and Pharmacotherapy. 141, 111834.Research output: Contribution to journal › Article › peer-review
Open Access7 Citations (Scopus) -
Carfilzomib and paclitaxel co-loaded protein nanoparticles an effective therapy against pancreatic adenocarcinomas
Cheng, W. T., Ho, H. O., Lin, S. Y., Liu, D. Z., Chen, L. C. & Sheu, M. T., Oct 2021, In: International Journal of Nanomedicine. 16, p. 6825-6841 17 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Citations (Scopus) -
Reduction of breast tumor drug resistance by 2,3,5,4'-tetrahydroxystilbene for exhibition synergic chemotherapeutic effect
Chang, Y. Y., Lin, H. J., Hsiao, L. C., Lin, Y. F., Chang, C. S. & Liu, D. Z., Dec 2021, In: PLoS ONE. 16, 12 December, e0260533.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer
Chang, C. (Contributor), Hsieh, C. (Contributor), Chen, L. (Contributor), Su, C. (Contributor), Liu, D. (Contributor), Jhan, H. (Contributor), Ho, H. (Contributor) & Sheu, M. (Contributor), Unknown Publisher, Jan 1 2018
DOI: 10.6084/m9.figshare.5908795.v1, https://tandf.figshare.com/articles/Novel_application_of_pluronic_lecithin_organogels_PLOs_for_local_delivery_of_synergistic_combination_of_docetaxel_and_cisplatin_to_improve_therapeutic_efficacy_against_ovarian_cancer/5908795/1
Dataset
-
Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer
Hsieh, C. (Contributor), Chen, L. (Contributor), Liu, D. (Contributor), Ho, H. (Contributor), Su, C. (Contributor), Sheu, M. (Contributor), Jhan, H. (Contributor) & Chang, C. (Contributor), Unknown Publisher, 2018
DOI: 10.6084/m9.figshare.5908795, https://doi.org/10.6084%2Fm9.figshare.5908795
Dataset